Nasvax Raises $1M

Israeli immunotherapeutic developer Nasvax has announced that it has raised $1 million. The sum was raised from Chinese firm Acebright, which develops cancer and infectious disease treatments.

Acebright’s investment will give it 10 percent ownership of the Israeli company. The Chinese company also said that it might participate in further financing rounds held by Nasvax.